Skip to search formSkip to main contentSkip to account menu

SM 20302

Known as: SM-20302 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzene Derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Pharmacological profile of a novel platelet glycoprotein 2b/3a antagonist SM-20302
2004
2004
Pharmacological Profile of a Novel Platelet Glycoprotein IIb/IIIa Antagonist SM-20302
2001
2001
Protective effects of SM-20302, an orally active GPIIb/IIIa antagonist, in an ADP/epinephrine-induced guinea pig model of transient cerebral ischemia.
1999
1999
Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.
1999
1999
Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs.
1998
1998
Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs.
We examined the pharmacokinetic and pharmacodynamic properties of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized… 
1998
1998
In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood.
We tested the hypothesis that the in vivo antithrombotic efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)